• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

门诊静脉注射用抗菌药物治疗(OPAT)中与蜂窝织炎治疗持续时间相关的临床和操作因素。

Clinical and operational factors associated with treatment duration for cellulitis in outpatient parenteral antimicrobial therapy (OPAT).

机构信息

Department of Infection and Tropical Medicine, Royal Hallamshire Hospital, Sheffield, UK.

Department of Infection, Immunity & Cardiovascular Diseases, University of Sheffield, Sheffield, UK.

出版信息

Diagn Microbiol Infect Dis. 2021 May;100(1):115305. doi: 10.1016/j.diagmicrobio.2020.115305. Epub 2021 Jan 6.

DOI:10.1016/j.diagmicrobio.2020.115305
PMID:33454560
Abstract

This study aims to identify factors associated with duration of intravenous (IV) and follow-on oral antibiotic therapy for cellulitis in patients treated through outpatient parenteral antimicrobial therapy (OPAT). A retrospective review of episodes of cellulitis treated over a year (January 2018-January 2019) at a large teaching hospital in Sheffield, UK. Overall, 292 OPAT episodes of cellulitis were reviewed. The mean durations of IV therapy and follow-on oral antibiotics were 5.3 days (range 1-32 days) and 6.1 days (range 2-17 days), respectively. Age, peak C-reactive protein and frequency of medical assessments during OPAT were independently associated with longer duration of IV therapy. Senior clinicians were likely to prescribe shorter courses of follow-on oral antibiotics. IV to oral conversion was more likely to occur on the first day of the work week. Our findings suggest that clinical and OPAT-related factors can influence early conversion to oral antibiotic therapy.

摘要

本研究旨在确定与门诊静脉输注抗菌药物治疗(outpatient parenteral antimicrobial therapy,OPAT)患者蜂窝织炎静脉(IV)和后续口服抗生素治疗持续时间相关的因素。对英国谢菲尔德一家大型教学医院一年(2018 年 1 月至 2019 年 1 月)期间治疗的蜂窝织炎发作进行回顾性分析。共回顾了 292 例 OPAT 蜂窝织炎发作。IV 治疗和后续口服抗生素的平均持续时间分别为 5.3 天(范围为 1-32 天)和 6.1 天(范围为 2-17 天)。年龄、峰值 C 反应蛋白和 OPAT 期间的医疗评估频率与 IV 治疗时间的延长独立相关。资深临床医生可能会开较短疗程的后续口服抗生素。IV 到口服的转换更有可能在工作周的第一天发生。我们的研究结果表明,临床和 OPAT 相关因素可能会影响早期转为口服抗生素治疗。

相似文献

1
Clinical and operational factors associated with treatment duration for cellulitis in outpatient parenteral antimicrobial therapy (OPAT).门诊静脉注射用抗菌药物治疗(OPAT)中与蜂窝织炎治疗持续时间相关的临床和操作因素。
Diagn Microbiol Infect Dis. 2021 May;100(1):115305. doi: 10.1016/j.diagmicrobio.2020.115305. Epub 2021 Jan 6.
2
Risk factors for amendment in type, duration and setting of prescribed outpatient parenteral antimicrobial therapy (OPAT) for adult patients with cellulitis: a retrospective cohort study and CART analysis.成人蜂窝织炎患者规定的门诊静脉用抗菌治疗(OPAT)类型、持续时间和设定修订的风险因素:回顾性队列研究和 CART 分析。
Postgrad Med J. 2018 Jan;94(1107):25-31. doi: 10.1136/postgradmedj-2017-134968. Epub 2017 Sep 5.
3
Role of outpatient parenteral antibiotic therapy in the treatment of community acquired skin and soft tissue infections in Singapore.门诊胃肠外抗生素治疗在新加坡社区获得性皮肤及软组织感染治疗中的作用
BMC Infect Dis. 2017 Jul 6;17(1):474. doi: 10.1186/s12879-017-2569-4.
4
Evaluation of an emergency department to outpatient parenteral antibiotic therapy program for cellulitis.评价一个用于治疗蜂窝织炎的急诊到门诊的抗生素治疗项目。
Am J Emerg Med. 2019 Nov;37(11):2008-2014. doi: 10.1016/j.ajem.2019.02.023. Epub 2019 Feb 21.
5
The impact of an outpatient parenteral antibiotic therapy (OPAT) clinic for adults with cellulitis: an interrupted time series study.门诊静脉用抗生素治疗(OPAT)成人蜂窝织炎门诊的影响:一项中断时间序列研究。
Intern Emerg Med. 2021 Oct;16(7):1935-1944. doi: 10.1007/s11739-021-02631-0. Epub 2021 Jan 30.
6
Oral antimicrobial therapy for cellulitis versus outpatient parenteral antimicrobial therapy: a single-centre audit of cellulitis outcomes.口服抗菌治疗与门诊静脉用抗菌治疗蜂窝织炎的疗效比较:单中心蜂窝织炎结局的审计研究。
Intern Med J. 2024 Feb;54(2):320-327. doi: 10.1111/imj.16173. Epub 2023 Jul 18.
7
The use, appropriateness and outcomes of outpatient parenteral antimicrobial therapy.门诊胃肠外抗菌治疗的使用、合理性及结果。
Arch Dis Child. 2016 Oct;101(10):886-93. doi: 10.1136/archdischild-2015-309731. Epub 2016 May 10.
8
Inequitable access to an outpatient parenteral antimicrobial therapy service: linked cross-sectional study.门诊肠外抗菌治疗服务可及性的不公平:关联横断面研究。
Int J Equity Health. 2020 Sep 1;19(1):150. doi: 10.1186/s12939-020-01261-w.
9
Mandatory infectious diseases approval of outpatient parenteral antimicrobial therapy (OPAT): clinical and economic outcomes of averted cases.强制性传染病审批对门诊患者静脉用抗菌药物治疗(OPAT)的影响:避免发生病例的临床和经济结局。
J Antimicrob Chemother. 2014 Jun;69(6):1695-700. doi: 10.1093/jac/dku015. Epub 2014 Feb 13.
10
Outpatient Parenteral Antimicrobial Therapy and Judicious Use of Pediatric Emergency Resources.门诊胃肠外抗菌治疗与儿科急诊资源的合理使用。
Pediatr Emerg Care. 2020 May;36(5):e247-e253. doi: 10.1097/PEC.0000000000001215.

引用本文的文献

1
Delivery of Outpatient Parenteral Antimicrobial Therapy (OPAT) in an Ever-Changing National Health Service (UK): Benefits, Barriers, and Opportunities.在不断变化的英国国民医疗服务体系中提供门诊肠外抗菌治疗(OPAT):益处、障碍与机遇
Antibiotics (Basel). 2025 Apr 29;14(5):451. doi: 10.3390/antibiotics14050451.
2
Recent Updates in Antimicrobial Stewardship in Outpatient Parenteral Antimicrobial Therapy.门诊胃肠外抗菌治疗中抗菌药物管理的最新进展
Curr Infect Dis Rep. 2021;23(12):24. doi: 10.1007/s11908-021-00766-x. Epub 2021 Nov 9.